Clinical trial
Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With…
NCT00351286 · Angiogenix, Industry · Unknown status
Key facts
| NCT number | NCT00351286 |
|---|---|
| Title | Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease |
| Official title | Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral L-Citrulline Compared to Placebo in Patients Taking Background Simvastatin 40 mg qD and With Peripheral Arterial Disease Including Intermittent Claudication |
| Lead sponsor | Angiogenix, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Arterial Disease, Intermittent Claudication |
| Intervention type | Drug |
| Interventions | L-citrulline tablets, 1000 mg, Placebo tablets matching L-citrulline tablets, Background simvastatin at a stable dose of 40 mg qHS |
| Enrollment | 160 |
| Start date | Mar 1, 2006 |
| First posted | Jul 12, 2006 |
| Last update posted | Oct 18, 2006 |
| Countries | Russia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: